IV Acetaminophen — Competitive Intelligence Brief

IV Acetaminophen (IV Acetaminophen) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Analgesic and antipyretic. Area: Pain Management.

marketed Analgesic and antipyretic Cyclooxygenase (COX) enzymes Pain Management Small molecule

Target snapshot

IV Acetaminophen (IV Acetaminophen) — Mallinckrodt. Acetaminophen inhibits prostaglandin synthesis in the central nervous system to reduce pain and fever.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
IV Acetaminophen TARGET	IV Acetaminophen	Mallinckrodt	marketed	Analgesic and antipyretic	Cyclooxygenase (COX) enzymes
Per Os Acetaminophen	Per Os Acetaminophen	Hospital for Special Surgery, New York	marketed	Non-opioid analgesic and antipyretic	Cyclooxygenase (COX), primarily in central nervous system
Panadol®	Panadol®	Sinew Pharma Inc.	marketed	Analgesic and antipyretic (non-NSAID)	Cyclooxygenase (COX), primarily in central nervous system
Acetaminophen/APAP	Acetaminophen/APAP	John van den Anker	marketed	Analgesic and antipyretic	Cyclooxygenase (COX), primarily central nervous system isoforms
Infusion with paracetamol	Infusion with paracetamol	University of Helsinki	marketed	Analgesic and antipyretic	Cyclooxygenase (COX) enzymes
Acetaminophen Injectable Product	Acetaminophen Injectable Product	Rush University Medical Center	marketed	Analgesic and antipyretic	Cyclooxygenase (COX) enzymes
Acetaminophen tablets	Acetaminophen tablets	Maoxiang Group Jilin Pharmaceutical Co., Ltd.	marketed	Analgesic and antipyretic	Cyclooxygenase (COX), primarily in central nervous system

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Analgesic and antipyretic class)

1. Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · 2 drugs in this class
2. Mallinckrodt · 2 drugs in this class
3. The University of Texas Health Science Center, Houston · 2 drugs in this class
4. Hellenic Society of Hematology · 1 drug in this class
5. John van den Anker · 1 drug in this class
6. Johnson & Johnson Consumer Inc., McNeil Consumer Healthcare Division · 1 drug in this class
7. Maoxiang Group Jilin Pharmaceutical Co., Ltd. · 1 drug in this class
8. Merck Sharp & Dohme LLC · 1 drug in this class
9. Mount Sinai Hospital, Canada · 1 drug in this class
10. Nantes University Hospital · 1 drug in this class